RU EN

Gulya M.O.

Candidate of Medical Sciences

Laboratory of Nuclear Medicine

H-index: RSCI 7, Scopus 4, Web of Science 3

Working experience

Marina O. Gulya has been a working in a position of Radiologist at the Department of Nuclear Medicine, Cardiology Research Institute, Tomsk NRMC.

Education and advanced professional training

In 2010, Marina O. Gulya graduated with honors from the Siberian State Medical University and was conferred a qualification of Doctor of Medicine (General Medicine). After graduation from the university, she completed the internship training in Radiology at the Department of Diagnostic Radiology and Radiotherapy at Siberian State Medical University (2010–2011). After that, she completed the medical residency program with specialty in Radiology at the Cardiology Research Institute. She has three valid certificates in Roentgenology, Radiology, and Ultrasound Diagnostics. In 2015, Marina O. Gulya defended thesis of dissertation titled «Myocardial perfusion-metabolic scintigraphy to predict outcomes of interventional and surgical correction of the left ventricular contractile dysfunction» (specialties: 14.01.13 — Radiology, Radiotherapy; 14.01.05 — Cardiology).

Research interests

Research interests focus on the area of studying the relationships between a degree of atherosclerotic damage to the coronary arteries and metabolic state and microcirculation of the left ventricular myocardium based on scintigraphy data. RSCI h-index = 5, Web of Science h-index = 1, Scopus h-index = 3.

Membership in societies, councils, and commissions

  • Member of the Russian Society of Roentgenologists and Radiologists
  • Member of the Russian Society of Nuclear Medicine
  • Member of the Russian Society of Cardiology
  • Member of the European Society of Radiology
  • Member of the European Society of Nuclear Medicine

Main publications, patents, and certificates

As of 2020, 22 articles has been published.

Chapters in books

  • Chernyavsky A.M., Edemsky A.G., Novikova N.v. , et al. Surgical treatment of chronic thromboembolic pulmonary hypertension. Ed.: A. M. Chernyavsky. Novosibirsk: Publishing House of the Siberian Branch of RAS, 2019. 318 p.
  • Lishmanov Y.B., Zavadovsky K.v. , Varlamova Y.B., Grakova E.v. , Gulya M.O., Ilushenkova Y.N., Sazonova S.I., Saushkin v. V., Chernov B. I. Practical guide to cardiac scintigraphy. Tomsk, 2018, 168 p.
  • Gamma-scintigraphy of the myocardium with radiopharmaceuticals based on lipid acids. Ed.: Y. B. Kishmanov. Tomsk: Novye Pechatnye Technologii, 2015. 188 p.

Articles

  1. Mochula A.V., Kopeva K.V., Maltseva A.N., Grakova E.V., Gulya M., Smorgon A.V., Gusakova A., Zavadovsky K.V. The myocardial flow reserve in patients with heart failure with preserved ejection fraction. Heart and Vessels 2023;38(3):348-360.
  2. Zavadovsky K.V., Mochula A.V., Boshchenko A.A., Vrublevsky A.V., Baev A.E., Krylov A.L., Gulya M.O., Nesterov E.A., Liga R., Gimelli A. Absolute myocardial blood flows derived by dynamic CZT scan versus invasive fractional flow reserve: correlation and accuracy. Journal of Nuclear Cardiology 2021;28(1):249-259.
  3. Zavadovsky K.V., Mochula A.V., Maltseva A.N., Shipulin V.V., Sazonova S.I., Gulya M.O., Liga R., Gimelli A. The current status of CZT SPECT myocardial blood flow and reserve assessment: Tips and tricks. Journal of Nuclear Cardiology 2021; :1-15.
  4. Zavadovsky K.V., Gulya M.O., Lishmanov Y.B., Lebedev D.I. Perfusion and metabolic scintigraphy with 123I-BMIPP in prognosis of cardiac resynchronization therapy in patients with dilated cardiomyopathy. Annals of Nuclear Medicine 2016;30(5):325-333.
  5. Zavadovsky K.V., Gulya M.O., Lishmanov Y.B., Verkhoturova V.V. Use of Technetium-99m-labeled lipophilic complex of methoxyisobutyl-isonitrile and iopromide radiopaque substance to assess the severity of coronary atherosclerosis in patients with coronary heart disease at mild disorders of myocardial perfusion. Advanced Materials Research 2015;1084:527-531.
  6. Lishmanov Y.B., Zavadovsky K.V., Gulya M.O., Minin S.M., Lebedev D.I. Use of Technetium-99m-labeled methoxy-isobutyl isonitrile and iodine 123-labeled phenyl-methyl-pentadecanoic acid in the diagnosis and prognosis of patients with dilated cardiomyopathy. Advanced Materials Research 2015;1084:532-535.
  7. Lishmanov Yu.B., Minin S.M., Saushkina Yu. V., Gulya M.O. Possibilities of cardiac scintigraphy with 123I-iodophen in patients with various forms of cardiomyopathies. Advanced Materials Research 2015;1084:417-421.